{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:36:52Z","timestamp":1793320612739,"version":"4.5.0"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>During the osteoarthritis (OA) process, activation of immune systems, whether innate or adaptive, is strongly associated with low-grade systemic inflammation. This process is initiated and driven in the synovial membrane, especially by synovium cells, themselves previously activated by damage-associated molecular patterns (DAMPs) released during cartilage degradation. These fragments exert their biological activities through pattern recognition receptors (PRRs) that, as a consequence, induce the activation of signaling pathways and beyond the release of inflammatory mediators, the latter contributing to the vicious cycle between cartilage and synovial membrane. The primary endpoint of this review is to provide the reader with an overview of these many molecules categorized as DAMPs and the contribution of the latter to the pathophysiology of OA. We will also discuss the different strategies to control their effects. We are convinced that a better understanding of DAMPs, their receptors, and associated pathological mechanisms represents a decisive issue for degenerative joint diseases such as OA.<\/jats:p>","DOI":"10.3389\/fmed.2020.607186","type":"journal-article","created":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T23:29:26Z","timestamp":1610926166000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":146,"title":["The Damage-Associated Molecular Patterns (DAMPs) as Potential Targets to Treat Osteoarthritis: Perspectives From a Review of the Literature"],"prefix":"10.3389","volume":"7","author":[{"given":"C\u00e9cile","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Zappia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Florin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Emile","family":"Dubuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Henrotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/rheumatology\/ket463","article-title":"Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries","volume":"53","author":"Kingsbury","year":"2014","journal-title":"Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: a disease of the joint as an organ","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3899\/jrheum.140382","article-title":"The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive","volume":"42","author":"Orlowsky","year":"2015","journal-title":"J Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11914-017-0411-y","article-title":"Immune contributions to osteoarthritis","volume":"15","author":"Lopes","year":"2017","journal-title":"Curr Osteoporos Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.joca.2015.03.036","article-title":"Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use","volume":"23","author":"Kraus","year":"2015","journal-title":"Osteoarthr Cartil."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.joca.2012.08.027","article-title":"Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review","volume":"20","author":"de","year":"2012","journal-title":"Osteoarthr Cartil."},{"key":"B7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11926-013-0323-5","article-title":"Synovium and the innate inflammatory network in osteoarthritis progression","volume":"15","author":"Liu-Bryan","year":"2013","journal-title":"Curr Rheumatol Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.bone.2012.02.012","article-title":"The role of synovitis in osteoarthritis pathogenesis","volume":"51","author":"Scanzello","year":"2012","journal-title":"Bone."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/jcp.26011","article-title":"Histomorphology and innate immunity during the progression of osteoarthritis: does synovitis affect cartilage degradation?","volume":"233","author":"Wang","year":"2018","journal-title":"J Cell Physiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/jcp.21258","article-title":"Osteoarthritis","volume":"213","author":"Goldring","year":"2007","journal-title":"J Cell Physiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nrrheum.2016.162","article-title":"The danger from within: alarmins in arthritis","volume":"12","author":"Nefla","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B13","first-page":"48","article-title":"Danger signals and inflammaging in osteoarthritis","volume":"37","author":"Millerand","year":"2019","journal-title":"Clin Exp Rheumatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1369\/0022155417740880","article-title":"Danger-associated molecular patterns derived from the extracellular matrix provide temporal control of innate immunity","volume":"66","author":"Frevert","year":"2017","journal-title":"J Histochem Cytochem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.14336\/AD.2018.0324","article-title":"Redefining chronic inflammation in aging and age-related diseases: proposal of the senoinflammation concept","volume":"10","author":"Chung","year":"2019","journal-title":"Aging Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nri3446","article-title":"The history of Toll-like receptors - redefining innate immunity","volume":"13","author":"O'Neill","year":"2013","journal-title":"Nat Rev Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bone.2016.01.019","article-title":"Inflammatory mediators in osteoarthritis: a critical review of the state-of-the-art, current prospects, and future challenges","volume":"85","author":"Rahmati","year":"2016","journal-title":"Bone."},{"key":"B18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1365-2613.2009.00676.x","article-title":"Analysing the role of endogenous matrix molecules in the development of osteoarthritis","volume":"90","author":"Sofat","year":"2009","journal-title":"Int J Exp Pathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1006\/abbi.1996.0461","article-title":"Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments","volume":"334","author":"Homandberg","year":"1996","journal-title":"Arch Biochem Biophys."},{"key":"B20","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s13075-015-0833-9","article-title":"Fibronectin fragment-induced expression of matrix metalloproteinases is mediated by MyD88-dependent TLR-2 signaling pathway in human chondrocytes","volume":"17","author":"Hwang","year":"2015","journal-title":"Arthritis Res Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.joca.2005.04.017","article-title":"Expression and regulation of Toll-like receptor 2 by IL-1beta and fibronectin fragments in human articular chondrocytes","volume":"13","author":"Su","year":"2005","journal-title":"Osteoarthr Cartil"},{"key":"B22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.lfs.2017.11.006","article-title":"Hyaluronan in experimental injured\/inflamed cartilage: in vivo studies","volume":"193","author":"Avenoso","year":"2018","journal-title":"Life Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"6947","DOI":"10.1007\/s00253-014-5853-x","article-title":"Insight into hyaluronic acid molecular weight control","volume":"98","author":"Marcellin","year":"2014","journal-title":"Appl Microbiol Biotechnol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.20001858","article-title":"Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4","volume":"195","author":"Termeer","year":"2002","journal-title":"J Exp Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"12762","DOI":"10.1074\/jbc.M806084200","article-title":"NLRP3\/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury","volume":"284","author":"Yamasaki","year":"2009","journal-title":"J Biol Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1007\/s00296-011-2067-8","article-title":"Tenascin-C fragments are endogenous inducers of cartilage matrix degradation","volume":"32","author":"Sofat","year":"2012","journal-title":"Rheumatol Int."},{"key":"B27","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nm.1987","article-title":"Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease","volume":"15","author":"Midwood","year":"2009","journal-title":"Nat Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/s41467-017-01718-7","article-title":"Mapping tenascin-C interaction with toll-like receptor 4 reveals a new subset of endogenous inflammatory triggers","volume":"8","author":"Zuliani-Alvarez","year":"2017","journal-title":"Nat Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1371\/journal.pone.0210601","article-title":"Prg4 prevents osteoarthritis induced by dominant-negative interference of TGF-\u00df signaling in mice","volume":"14","author":"Chavez","year":"2019","journal-title":"PLoS ONE."},{"key":"B30","doi-asserted-by":"publisher","first-page":"18910","DOI":"10.1038\/srep18910","article-title":"Lubricin\/Proteoglycan 4 binds to and regulates the activity of toll-like receptors in vitro","volume":"6","author":"Iqbal","year":"2016","journal-title":"Sci Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/biom10010080","article-title":"From translation to protein degradation as mechanisms for regulating biological functions: a review on the SLRP family in skeletal tissues","volume":"10","author":"Zappia","year":"2020","journal-title":"Biomolecules."},{"key":"B32","doi-asserted-by":"publisher","first-page":"32301","DOI":"10.1074\/jbc.M504828200","article-title":"The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q","volume":"280","author":"Sjoberg","year":"2005","journal-title":"J Biol Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.molimm.2008.09.018","article-title":"Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation","volume":"46","author":"Sjoberg","year":"2009","journal-title":"Mol Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1172\/JCI23755","article-title":"The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages","volume":"115","author":"Schaefer","year":"2005","journal-title":"J Clin Invest."},{"key":"B35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s13075-015-0902-0","article-title":"Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis","volume":"17","author":"Barreto","year":"2015","journal-title":"Arthritis Res Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.abb.2018.01.007","article-title":"The proteoglycan biglycan mediates inflammatory response by activating TLR-4 in human chondrocytes: inhibition by specific siRNA and high polymerized Hyaluronan","volume":"640","author":"Avenoso","year":"2018","journal-title":"Arch Biochem Biophys."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1179544117751430","DOI":"10.1177\/1179544117751430","article-title":"Osteoarthritis and the complement cascade","volume":"11","author":"Silawal","year":"2018","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord."},{"key":"B38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1089\/ten.teb.2013.0377","article-title":"The roles of catabolic factors in the development of osteoarthritis","volume":"20","author":"Blasioli","year":"2014","journal-title":"Tissue Eng Part B Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1189\/jlb.1206730","article-title":"The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4","volume":"82","author":"Gondokaryono","year":"2007","journal-title":"J Leukoc Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.clindermatol.2010.11.003","article-title":"Extra domain A-positive fibronectin-positive feedback loops and their association with cutaneous inflammatory disease","volume":"29","author":"McFadden","year":"2011","journal-title":"Clin Dermatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e102974","DOI":"10.1371\/journal.pone.0102974","article-title":"Regulation of the innate immune response by fibronectin: synergism between the III-1 and EDA domains","volume":"9","author":"Kelsh","year":"2014","journal-title":"PLoS ONE."},{"key":"B42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/jor.20716","article-title":"A critical role for collagen II in cartilage matrix degradation: collagen II induces pro-inflammatory cytokines and MMPs in primary human chondrocytes","volume":"27","author":"Klatt","year":"2009","journal-title":"J Orthop Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1074\/jbc.M704915200","article-title":"Cathepsins B, K, and L are regulated by a defined collagen type II peptide via activation of classical protein kinase C and p38 MAP kinase in articular chondrocytes","volume":"283","author":"Ruettger","year":"2008","journal-title":"J Biol Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/jor.20001","article-title":"Collagen degradation products modulate matrix metalloproteinase expression in cultured articular chondrocytes","volume":"24","author":"Fichter","year":"2006","journal-title":"J Orthop Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.matbio.2007.01.006","article-title":"Chondrocyte hypertrophy can be induced by a cryptic sequence of type II collagen and is accompanied by the induction of MMP-13 and collagenase activity: implications for development and arthritis","volume":"26","author":"Tchetina","year":"2007","journal-title":"Matrix Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2220\/biomedres.35.193","article-title":"Type II collagen peptide stimulates Akt leading to nuclear factor-kappaB activation: its inhibition by hyaluronan","volume":"35","author":"Yasuda","year":"2014","journal-title":"Biomed Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.joca.2019.07.009","article-title":"Type II collagen peptide Coll2-1 is an actor of synovitis","volume":"27","author":"Lambert","year":"2019","journal-title":"Osteoarthr Cartil."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/art.39063","article-title":"Bioactivity in an Aggrecan 32-mer fragment is mediated via toll-like receptor 2","volume":"67","author":"Lees","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"27915","DOI":"10.1074\/jbc.M111.242834","article-title":"NC4 Domain of cartilage-specific collagen IX inhibits complement directly due to attenuation of membrane attack formation and indirectly through binding and enhancing activity of complement inhibitors C4B-binding protein and factor H","volume":"286","author":"Kalchishkova","year":"2011","journal-title":"J Biol Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1002\/art.27720","article-title":"Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis","volume":"62","author":"Happonen","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B51","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.4049\/jimmunol.175.7.4715","article-title":"Interactions of the extracellular matrix proteoglycans decorin and biglycan with C1q and collectins","volume":"175","author":"Groeneveld","year":"2005","journal-title":"J Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nrc2345","article-title":"Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer","volume":"8","author":"Bellahcene","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"B53","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.joca.2009.07.009","article-title":"Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients","volume":"18","author":"Gao","year":"2010","journal-title":"Osteoarthr Cartil."},{"key":"B54","first-page":"316","article-title":"Osteopontin stimulates matrix metalloproteinase expression through the nuclear factor-kappaB signaling pathway in rat temporomandibular joint and condylar chondrocytes","volume":"9","author":"Ding","year":"2017","journal-title":"Am J Transl Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.molmet.2016.09.003","article-title":"Osteopontin is a key player for local adipose tissue macrophage proliferation in obesity","volume":"5","author":"Tardelli","year":"2016","journal-title":"Mol Metab."},{"key":"B56","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1186\/ar3555","article-title":"Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4","volume":"14","author":"Sohn","year":"2012","journal-title":"Arthritis Res Ther."},{"key":"B57","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/ar2172","article-title":"High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis","volume":"9","author":"Gobezie","year":"2007","journal-title":"Arthritis Res Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1002\/art.21373","article-title":"Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity","volume":"52","author":"Loeuille","year":"2005","journal-title":"Arthritis Rheum."},{"key":"B59","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/art.30081","article-title":"Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcgamma receptor","volume":"63","author":"Sokolove","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.4049\/jimmunol.167.5.2887","article-title":"Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4","volume":"167","author":"Smiley","year":"2001","journal-title":"J Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/art.34315","article-title":"Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis","volume":"64","author":"van Lent","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/art.33495","article-title":"Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4","volume":"64","author":"Schelbergen","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1007\/s10067-019-04718-8","article-title":"Associations between serum IL-8 and knee symptoms, joint structures, and cartilage or bone biomarkers in patients with knee osteoarthritis","volume":"38","author":"Ruan","year":"2019","journal-title":"Clin Rheumatol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/art.39420","article-title":"Induction of canonical Wnt signaling by the alarmins S100A8\/A9 in murine knee joints: implications for osteoarthritis","volume":"68","author":"van den Bosch","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1182\/blood-2009-06-226944","article-title":"Annexin A2 tetramer activates human and murine macrophages through TLR4","volume":"115","author":"Swisher","year":"2010","journal-title":"Blood."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00011-012-0519-6","article-title":"Regulation of inflammatory response in human chondrocytes by lentiviral mediated RNA interference against S100A10","volume":"61","author":"Song","year":"2012","journal-title":"Inflamm Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.bbrc.2012.05.036","article-title":"Role of S100A12 in the pathogenesis of osteoarthritis","volume":"422","author":"Nakashima","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"B68","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3109\/1354750X.2013.766262","article-title":"S100A12 levels in synovial fluid may reflect clinical severity in patients with primary knee osteoarthritis","volume":"18","author":"Wang","year":"2013","journal-title":"Biomarkers"},{"key":"B69","doi-asserted-by":"publisher","first-page":"907078","DOI":"10.1155\/2012\/907078","article-title":"The role of S100A12 as a systemic marker of inflammation","volume":"2012","author":"Meijer","year":"2012","journal-title":"Int J Inflam."},{"key":"B70","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/rheumatology\/kep452","article-title":"Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases","volume":"49","author":"Baillet","year":"2010","journal-title":"Rheumatology."},{"key":"B71","doi-asserted-by":"publisher","first-page":"138","DOI":"10.2119\/molmed.2013.00164","article-title":"The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases","volume":"20","author":"Magna","year":"2014","journal-title":"Mol Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"809","DOI":"10.7754\/Clin.Lab.2015.141205","article-title":"Synovial fluid HMGB-1 levels are associated with osteoarthritis severity","volume":"61","author":"Ke","year":"2015","journal-title":"Clin Lab."},{"key":"B73","doi-asserted-by":"publisher","first-page":"369","DOI":"10.18926\/AMO\/47262","article-title":"Gene expression and localization of high-mobility group box chromosomal protein-1 (HMGB-1)in human osteoarthritic cartilage","volume":"65","author":"Terada","year":"2011","journal-title":"Acta Med Okayama."},{"key":"B74","doi-asserted-by":"publisher","first-page":"R165","DOI":"10.1186\/ar3124","article-title":"High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1beta in osteoarthritic synoviocytes","volume":"12","author":"Garcia-Arnandis","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/rheumatology\/ker524","article-title":"Microcrystals as DAMPs and their role in joint inflammation","volume":"51","author":"Busso","year":"2012","journal-title":"Rheumatology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.joca.2018.02.901","article-title":"NLRP3 as a potentially novel biomarker for the management of osteoarthritis","volume":"26","author":"McAllister","year":"2018","journal-title":"Osteoarthr Cartil 756."},{"key":"B77","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/BOR.0b013e3283432d1f","article-title":"Crystals, inflammation, and osteoarthritis","volume":"23","author":"Rosenthal","year":"2011","journal-title":"Curr Opin Rheumatol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1073\/pnas.1012743108","article-title":"Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation","volume":"108","author":"Denoble","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B80","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.4049\/jimmunol.174.8.5016","article-title":"TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation","volume":"174","author":"Liu-Bryan","year":"2005","journal-title":"J Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3390\/biology9040065","article-title":"Osteoarthritis and toll-like receptors: when innate immunity meets chondrocyte apoptosis","volume":"9","author":"Barreto","year":"2020","journal-title":"Biology."},{"key":"B82","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2249.2006.03203.x","article-title":"Translational mini-review series on toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity","volume":"147","author":"Parker","year":"2007","journal-title":"Clin Exp Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrrheum.2014.209","article-title":"TLR4 signalling in osteoarthritis\u2013finding targets for candidate DMOADs","volume":"11","author":"Gomez","year":"2015","journal-title":"Nat Rev Rheumatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1002\/art.21951","article-title":"The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes","volume":"54","author":"Kim","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B85","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11010-017-3047-4","article-title":"Damage-associated molecular patterns in the pathogenesis of osteoarthritis: potentially novel therapeutic targets","volume":"434","author":"Rosenberg","year":"2017","journal-title":"Mol Cell Biochem."},{"key":"B86","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/17453674.2017.1281058","article-title":"Toll-like receptors and their soluble forms differ in the knee and thumb basal osteoarthritic joints","volume":"88","author":"Barreto","year":"2017","journal-title":"Acta Orthop."},{"key":"B87","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/ar2729","article-title":"Toll-like receptors and NOD-like receptors in rheumatic diseases","volume":"11","author":"McCormack","year":"2009","journal-title":"Arthritis Res Ther."},{"key":"B88","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13075-015-0645-y","article-title":"Pattern recognition receptors as potential therapeutic targets in inflammatory rheumatic disease","volume":"17","author":"Mullen","year":"2015","journal-title":"Arthritis Res Ther."},{"key":"B89","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.immuni.2012.01.018","article-title":"Inflammasome activators induce interleukin-1alpha secretion via distinct pathways with differential requirement for the protease function of caspase-1","volume":"36","author":"Gross","year":"2012","journal-title":"Immunity"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.cellsig.2013.06.013","article-title":"Cellular signalling of the receptor for advanced glycation end products (RAGE)","volume":"25","author":"Xie","year":"2013","journal-title":"Cell Signal."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.12659\/MSM.895689","article-title":"Expression and significance of high-mobility group protein B1 (HMGB1) and the Receptor for Advanced Glycation End-Product (RAGE) in knee osteoarthritis","volume":"22","author":"Sun","year":"2016","journal-title":"Med Sci Monit."},{"key":"B92","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/biof.202","article-title":"Hyaluronan differently modulates TLR-4 and the inflammatory response in mouse chondrocytes","volume":"38","author":"Campo","year":"2012","journal-title":"BioFactors."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1111\/j.1742-4658.2012.08598.x","article-title":"Adenosine A2A receptor activation and hyaluronan fragment inhibition reduce inflammation in mouse articular chondrocytes stimulated with interleukin-1beta","volume":"279","author":"Campo","year":"2012","journal-title":"FEBS J"},{"key":"B94","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1371\/journal.pone.0066769","article-title":"Acute-phase serum amyloid A in osteoarthritis: regulatory mechanism and proinflammatory properties","volume":"8","author":"de Seny","year":"2013","journal-title":"PLoS ONE."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1080\/14656566.2016.1201070","article-title":"An update on the up and coming therapies to treat osteoarthritis, a multifaceted disease","volume":"17","author":"Roman-Blas","year":"2016","journal-title":"Expert Opin Pharmacother."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e27630","DOI":"10.1371\/journal.pone.0027630","article-title":"Interleukin-6 synthesis in human chondrocytes is regulated via the antagonistic actions of prostaglandin (PG)E2 and 15-deoxy-delta(12,14)-PGJ2","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS ONE."},{"key":"B97","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1196\/annals.1317.045","article-title":"VIP decreases TLR4 expression induced by LPS and TNF-alpha treatment in human synovial fibroblasts","volume":"1070","author":"Juarranz","year":"2006","journal-title":"Ann N Y Acad Sci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/mnfr.201200833","article-title":"6-Shogaol inhibits chondrocytes' innate immune responses and cathepsin-K activity","volume":"58","author":"Villalvilla","year":"2014","journal-title":"Mol Nutr Food Res"},{"key":"B99","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/imm.12312","article-title":"Anti-Toll-like receptor 2 and 4 antibodies suppress inflammatory response in mice","volume":"143","author":"Komai-Koma","year":"2014","journal-title":"Immunology."},{"key":"B100","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s13075-015-0877-x","article-title":"The interaction of lubricin\/proteoglycan 4 (PRG4) with toll-like receptors 2 and 4: an anti-inflammatory role of PRG4 in synovial fluid","volume":"17","author":"Alquraini","year":"2015","journal-title":"Arthritis Res Ther."},{"key":"B101","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2741\/4735","article-title":"Generation of sRAGEhigh transgenic mice to study inflammaging","volume":"24","author":"Peng","year":"2019","journal-title":"Front Biosci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.tmrv.2019.09.004","article-title":"Eculizumab and beyond: the past, present, and future of complement therapeutics","volume":"33","author":"Patriquin","year":"2019","journal-title":"Transfus Med Rev."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2119\/molmed.2010.00264","article-title":"Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models","volume":"17","author":"Schierbeck","year":"2011","journal-title":"Mol Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41589-019-0278-6","article-title":"MCCcloses the active conformation of NLRP3 to an inactive state","volume":"15","author":"Tapia-Abell\u00e1n","year":"2019","journal-title":"Nat Chem Biol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.biocel.2014.07.020","article-title":"Soluble biglycan as a biomarker of inflammatory renal diseases","volume":"54","author":"Hsieh","year":"2014","journal-title":"Int J Biochem Cell Biol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1365-2796.2011.02432.x","article-title":"High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus","volume":"270","author":"Urbonaviciute","year":"2011","journal-title":"J Intern Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.607186\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T23:29:35Z","timestamp":1610926175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.607186\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,18]]},"references-count":106,"alternative-id":["10.3389\/fmed.2020.607186"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.607186","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,18]]},"article-number":"607186"}}